These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12650821)

  • 1. Pegylated interferon-2b-associated autoimmune thrombocytopenia in a patient with chronic hepatitis C.
    Sevastianos VA; Deutsch M; Dourakis SP; Manesis EK
    Am J Gastroenterol; 2003 Mar; 98(3):706-7. PubMed ID: 12650821
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus.
    Cholongitas E; Samonakis D; Patch D; Senzolo M; Burroughs AK; Quaglia A; Dhillon A
    Transplantation; 2006 Feb; 81(3):488-90. PubMed ID: 16477242
    [No Abstract]   [Full Text] [Related]  

  • 3. [Safety of pegylated interferon in patients with hepatitis C virus induced cirrhosis].
    Gasztonyi B; Pár G; Pár A; Hunyady B
    Orv Hetil; 2005 Nov; 146(48):2431-4. PubMed ID: 16408382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late onset autoimmune thrombocytopenia associated with pegylated interferon-alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Elefsiniotis IS; Pantazis KD; Fotos NV; Moulakakis A; Mavrogiannis C
    J Gastroenterol Hepatol; 2006 Mar; 21(3):622-3. PubMed ID: 16638114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence.
    Hrachovec J; Patel P
    Gastroenterology; 2003 Jun; 124(7):2003-4; author reply 2004-5. PubMed ID: 12812198
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence.
    Lodato F; Tame MR; Colecchia A; Racchini C; Azzaroli F; D'Errico A; Casanova S; Pinna A; Roda E; Mazzella G
    World J Gastroenterol; 2006 Jul; 12(26):4253-5. PubMed ID: 16830387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.
    Kontorinis N; Agarwal K; Elhajj N; Fiel MI; Schiano TD
    Liver Transpl; 2006 May; 12(5):827-30. PubMed ID: 16628699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
    Hunyady B; Kovács B; Battyáni Z
    Orv Hetil; 2011 Dec; 152(50):1997-2009. PubMed ID: 22112373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.
    Sagir A; Wettstein M; Heintges T; Häussinger D
    Dig Dis Sci; 2002 Mar; 47(3):562-3. PubMed ID: 11911342
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of autoimmune hepatitis by pegylated interferon alfa-2b in chronic hepatitis C.
    Lörke J; Erhardt A; Häussinger D
    Clin Gastroenterol Hepatol; 2004 Dec; 2(12):xx. PubMed ID: 15625645
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe neutropenia and post-hepatitis C cirrhosis treatment: is interferon dose adaptation at once necessary?
    Renou C; Harafa A; Bouabdallah R; Dematteï C; Cummins C; Rifflet H; Muller P; Ville E; Bertrand J; Benderitter T; Halfon P
    Am J Gastroenterol; 2002 May; 97(5):1260-3. PubMed ID: 12014740
    [No Abstract]   [Full Text] [Related]  

  • 12. The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
    van Zonneveld M; Flink HJ; Verhey E; Senturk H; Zeuzem S; Akarca US; Cakaloglu Y; Simon C; So TM; Gerken G; de Man RA; Hansen BE; Schalm SW; Janssen HL;
    Aliment Pharmacol Ther; 2005 May; 21(9):1163-71. PubMed ID: 15854180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
    Vinagre I; Rigla M; Torras X; Enríquez J; Corcoy R
    Endocrinol Nutr; 2010 Oct; 57(8):393-5. PubMed ID: 20462813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pegylated-interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C].
    Primo Vera J
    Gastroenterol Hepatol; 2004 Feb; 27(2):69. PubMed ID: 14733882
    [No Abstract]   [Full Text] [Related]  

  • 15. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis.
    Hayashi PH; Mehia C; Joachim Reimers H; Solomon HS; Bacon BR
    J Clin Gastroenterol; 2006 Sep; 40(8):740-4. PubMed ID: 16940889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis.
    Maan R; van der Meer AJ; Hansen BE; Feld JJ; Wedemeyer H; Dufour JF; Zangneh HF; Lammert F; Manns MP; Zeuzem S; Janssen HL; de Knegt RJ; Veldt BJ
    J Hepatol; 2014 Sep; 61(3):482-91. PubMed ID: 24780302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid development of severe thrombocytopenia in a female with chronic hepatitis C after single-dose pegylated interferon therapy.
    Huang HH; Lin CF; Shih YL; Chang WK; Hsieh TY
    Dig Liver Dis; 2010 Mar; 42(3):233-4. PubMed ID: 19592316
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis.
    Meyer-Wyss B; Rich P; Egger H; Helbling B; Müllhaupt B; Rammert C; Gonvers JJ; Oneta C; Criblez D; Rossi L; Borovicka J; Meyenberger C; Arn M; Renner EL;
    J Viral Hepat; 2006 Jul; 13(7):457-65. PubMed ID: 16792539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pegylated interferon treatment and severe thrombocytopenia].
    Rodríguez-García G; Jiménez-Macías F; Fernández-Jurado A; Domínguez-Macías A
    Med Clin (Barc); 2006 Sep; 127(8):316-7. PubMed ID: 16949021
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe streptococcal cellulitis after subcutaneous pegylated interferon alfa-2B in a diabetic patient.
    Lanternier F; Bon C; Memain N; Roulot D; Lortholary O
    Gastroenterol Clin Biol; 2004 Dec; 28(12):1294-5. PubMed ID: 15671943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.